High-Level Multiplex Genotyping of Polymorphisms Involved in Folate or Homocysteine Metabolism by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry

Clinical Chemistry

Volumn 50, Issue 2, 2004, Pages 391-402

  Meyer, Klaus ^a   Fredriksen, Åse ^a   Ueland, Per Magne ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARYLDIALKYLPHOSPHATASE; BETAINE; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE; REDUCED FOLATE CARRIER; TRANSCOBALAMIN II;

AMINO ACID BLOOD LEVEL; AMINO ACID SYNTHESIS; ANALYTICAL ERROR; ARTICLE; CALIBRATION; CONTROLLED STUDY; DNA POLYMORPHISM; DNA PURIFICATION; ENZYME ASSAY; FOLIC ACID BLOOD LEVEL; GENE IDENTIFICATION; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SINGLE NUCLEOTIDE POLYMORPHISM;

FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0742286981     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.026799     Document Type: Article

References (71)

1. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
2. den Heijer M Keijzer MB. Hyperhomocysteinemia as a risk factor for venous thrombosis. Clin Chem Lab Med 2001;39:710-3.
3. Delport R. Hyperhomocyst(e)inemia, related vitamins and dementias. J Nutr Health Aging 2000;4:195-6.
4. Miller JW. Homocysteine and Alzheimer's disease. Nutr Rev 1999;57:126-9.
5. 12 and homocysteine in relation to birth defects and pregnancy outcome. Br J Nutr 2001;85(Suppl 2):S109-13.
6. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
7. Daly L, Robinson K, Tan KS, Graham IM. Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences?. Q J Med 1993;86: 685-9.
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
9. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001;22:195-201.
10. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-72.
11. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-51.
12. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7.
13. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999;17:298-309.
14. 12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8:825-9.
15. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999;67:317-23.
16. Brown CA, McKinney KQ, Kaufman JS, Gravel RA, Rozen R. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk 2000;7:197-200.
17. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yamell JW, et al. The methionine synthase reductase (MTRR) A66G polymorphism Is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001;157:451-6.
18. Speer MC, Nye J, McLone D, Worley G, Melvin EC, Viles KD, et al. Possible interaction of genotypes at cystathionine β-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group. Clin Genet 1999;56:142-4.
19. Tsai MY, Yang F, Bignell M, Aras O, Hanson NQ. Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine β-synthase gene, and pyridoxal-5′-phosphate concentration. Mol Genet Metab 1999;67:352-6.
20. de Franchis R, Fermo I, Mazzola G, Sebastio G, Di Minno G, Coppola A, et al. Contribution of the cystathionine β-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia. Thromb Haemost 2000;84:576-82.
21. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002;13: 239-48.
22. Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, et al. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab 2000;70:53-60.
23. Aras O, Hanson NQ, Yang F, Tsai MY. Influence of 699C→T and 1080C→;T polymorphisms of the cystathionine β-synthase gene on plasma homocysteine levels. Clin Genet 2000;58:455-9.
24. McCaddon A, Blennow K, Hudson P, Regland B, Hill D. Transcobalamin polymorphism and homocysteine. Blood 2001;98: 3497-9.
25. Namour F, Olivier J, Abdelmouttaleb I, Adjalla C, Debard R, Salvat C, et al. Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood 2001;97:1092-8.
26. Afman LA, Lievers KJ, Van Der Put NM, Trijbels FJ, Blom HJ. Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet 2002;10:433-8.
27. 12 status in healthy older adults. Blood 2002;100:718-20.
28. Zetterberg H, Regland B, Palmer M, Rymo L, Zafiropoulos A, Arvanitis DA, et al. The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion. Hum Reprod 2002;17:3033-6.
29. Lievers KJA, Afman LA, Kluijtmans LAJ, Boers GHJ, Verhoef P, den Heijer M, et al. Polymorphisms in the transcobalamin gene: associations with homocysteine concentrations and cardiovascular disease risk. Clin Chem 2002;48:1383-9.
30. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, et al. A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000;70:310-5.
31. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Cama A, et al. Polymorphisms in genes involved in folate metabolism as risk factors for NTDs. Eur J Pediatr Surg 2001;11(Suppl 1):S14-7.
32. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 2002;108:1-6.
33. De Marco P, Calevo MG, Moroni A, Merello E, Raso A, Finnell RH, et al. Reduced folate carrier polymorphism (80A→G) and neural tube defects. Eur J Hum Genet 2003;11:245-52.
34. Morin I, Platt R, Weisberg I, Sabbaghian N, WuQ, Garrow TA, et al. Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet 2003;119A: 172-6.
35. Weisberg IS, Park E, Ballman KV, Berger P, Nunn M, Suh DS, et al. Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease. Atherosclerosis 2003;167:205-14.
36. Jakubowski H, Ambrosius WT, Pratt JH. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis. FEBS Lett 2001;491:35-9.
37. Voetsch B, Benke KS, Damasceno BP, Siqueira LH, Loscalzo J. Paraoxonase 192 Gln→Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 2002;33:1459-64.
38. Kwok PY. High-throughput genotyping assay approaches. Pharmacogenomics 2000;1:95-100.
39. Larsen LA, Christiansen M, Vuust J, Andersen PS. Recent developments in high-throughput mutation screening. Pharmacogenomics 2001;2:387-99.
40. Shi MM. Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies. Clin Chem 2001;47:164-72.
41. Tsuchihashi Z, Dracopoli NC. Progress in high throughput SNP genotyping methods. Pharmacogenomics J 2002;2:103-10.
42. Medintz IL, Paegel BM, Blazej RG, Emrich CA, Berti L, Scherer JR, et al. High-performance genetic analysis using microfabricated capillary array electrophoresis microplates. Electrophoresis 2001;22:3845-56.
43. Dong S, Wang E, Hsie L, Cao Y, Chen X, Gingeras TR. Flexible use of high-density oligonucleotide arrays for single-nucleotide polymorphism discovery and validation. Genome Res 2001;11:1418-24.
44. Michael KL, Taylor LC, Schultz SL, Walt DR. Randomly ordered addressable high-density optical sensor arrays. Anal Chem 1998; 70:1242-8.
45. Little DP, Cornish TJ, O'Donnel MJ, Braun A, Cotter RJ, Köster H. MALDI on a chip: analysis of arrays of low-femtomole to subfemtomole quantities of synthetic oligonucleotides and DNA diagnostic products by a piezoelectric pipet. Anal Chem 1997;69: 4540-6.
46. Bell PA, Chaturvedi S, Gelfand CA, Huang CY, Kochersperger M, Kopla R, et al. SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery [Erratum published in Biotechniques 2003;34:496]. Biotechniques 2002; Suppl:70-2,74,76-7.
47. De La Vega FM, Dailey D, Ziegle J, Williams J, Madden D, Gilbert DA. New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies. Biotechniques 2002;Suppl:48-50,52,54.
48. Sauer S, Gut IG. Genotyping single-nucleotide polymorphisms by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 2002;782:73-87.
49. Tost J, Gut IG. Genotyping single nucleotide polymorphisms by mass spectrometry. Mass Spectrom Rev 2002;21:388-418.
50. Wu KJ, Steding A, Becker CH. Matrix-assisted laser desorption time-of-flight mass spectrometry of oligonucleotides using 3-hydroxypicoline acid as an ultraviolet-sensitive matrix. Rapid Commun. Mass Spectrom 1993;7:142-6.
51. Lecchi P, Le HM, Pannell LK. 6-Aza-2-thiothymine: a matrix for MALDI spectra of oligonucleotides. Nucleic Acids Res 1995;23: 1276-7.
52. Zhu YF, Chung CN, Taranenko NI, Allman SL, Martin SA, Haff L, et al. The study of 2,3,4-trihydroxyacetophenone and 2,4,6-trihydroxyacetophenone as matrices for DNA detection in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1996;10:383-8.
53. Li YCL, Cheng S-W, Chan TWD. Evaluation of ammonium salts as co-matrices for matrix-assisted laser desorption/ionization mass spectrometry of oligonucleotides. Rapid Commun Mass Spectrom 1998;12:993-8.
54. Ragas JA, Simmons TA, Limbach PA. A comparative study on methods of optimal sample preparation for the analysis of oligonucleotides by matrix-assisted laser desorption/ionization mass spectrometry. Analyst 2000;125:575-81.
55. Schuerenberg M, Luebbert C, Eickhoff H, Kalkum M, Lehrach H, Nordhoff E. Prestructured MALDI-MS sample supports. Anal Chem 2000;72:3436-42.
56. Tang K, Fu DJ, Julien D, Braun A, Cantor CR, Koster H. Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci U S A 1999;96:10016-20.
57. Juhasz P, Roskey MT, Smirnov IP, Haff LA, Vestal ML, Martin SA. Applications of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry to oligonucleotide analysis. Anal Chem 1996;68:941-6.
58. Haff LA, Smirnov IP. Single-nucleotide polymorphism identification assays using a thermostable DNA polymerase and delayed extraction MALDI-TOF mass spectrometry. Genome Res 1997;7:378-88.
59. Braun A, Little DP, Köster H. Detecting CFTR gene mutations by using primer oligo base extension and mass spectrometry. Clin Chem 1997;43:1151-8.
60. Ross P, Hall L, Smirnov I, Haff L. High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 1998;16: 1347-51.
61. Ulvik A, Ueland PM. Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism. Clin Chem 2001;47:2050-3.
62. Nordhoff E, Ingendoh A, Cramer R, Overberg A, Stahl B, Karas M, et al. Matrix-assisted laser desorption/ionization mass spectrometry of nucleic acids with wavelengths in the ultraviolet and infrared. Rapid Commun Mass Spectrom 1992;6:771-6.
63. Gilar M, Blenky A, Wang BH. High-throughput biopolymer desalting by solid-phase extraction prior to mass spectrometric analysis. J. Chromatogr A 2001;921:3-13.
64. Smirnov IP, Hall LR, Ross PL, Haff LA. Application of DNA-binding polymers for preparation of DNA for analysis by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 2001;15:1427-32.
65. Barnes WM. PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates. Proc Natl Acad Sci U S A 1994;91:2216-20.
66. Bray MS, Boerwinkle E, Doris PA. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum Mutat 2001;17:296-304.
67. Lechner D, Lathrop GM, Gut IG. Large-scale genotyping by mass spectrometry: experience, advances and obstacles. Curr Opin Chem Biol 2002;6:31-8.
68. Nakai K, Habano W, Fujita T, Schnackenberg J, Kawazoe K, Suwabe A, et al. Highly multiplexed genotyping of coronary artery disease-associated SNPs using MALDI-TOF mass spectrometry. Hum Mutat 2002;20:133-8.
69. Sperandeo MP, de Franchis R. Andria G, Sebastio G. A 68-bp insertion found in a homocystinuric patient is a common variant and is skipped by alternative splicing of the cystathionine βsynthase mRNA. Am J Hum Genet 1996;59:1391-3.
70. Ross P, Hall L, Haff LA. Quantitative approach to single-nucleotide polymorphism analysis using MALDI-TOF mass spectrometry. Biotechniques 2000;29:620-6, 628-9.
71. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 2001;98:581-4.